MIRIKIZUMAB REDUCES ABDOMINAL PAIN IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE

Edward V. Loftus  1     Paul Pollack  2     Theresa Hunter  2     Mingyang Shan  2     Deanilee Deckard  2     Raymond Cross  3     Lai Shan Chan  4    
1 Mayo Clinic College of Medicine,Rochester,United States
2 Eli Lilly and Company,Indianapolis,United States
3 University of Maryland,Baltimore,United States
4 Eli Lilly and Company,Indianap

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing